Creabilis Raises $20M To Develop Dermatology Drugs
By Alex Ortolani · October 5, 2011, 6:18 PM EDT
European biotechnology company Creabilis SA said Tuesday it raised €15 million ($20 million) in funding led by Abbott Biotech Ventures Inc. to pay for the continued development of its most important drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login